Darzalex Faspro (Daratumumab and Hyaluronidase-Fihj)
Overview
Darzalex Faspro is approved by the U.S. Food and Drug Administration (FDA) for the treatment of newly diagnosed light chain (AL) amyloidosis in adults. This approval is under the FDA’s accelerated approval…